DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20221190

Evaluation of effect of amitriptyline and pregabalin on heart rate variability in neuropathic pain in non-diabetic patients

Rohan Srivastava, N. D. Kantharia

Abstract


Background: The effects of amitriptyline and pregabalin on heart rate variability (HRV) in patients with neuropathic pain in non-diabetic patients are poorly understood in India. The present study was conducted to evaluate the effect of amitriptyline and pregabalin on heart rate variability (HRV) and neuropathic pain in non-diabetic patients.

Methods: Forty adult patients (aged 18-65 years) of either sex diagnosed with neuropathic pain were divided into two groups. The study was prospective open label and observational study. Amitriptyline 10 mg once a day was given to group 1 while group 2 received pregabalin 75 mg once a day and HRV and pain score were recorded; and post-treatment data at 2 and 4 weeks were compared with pre-treatment values (control). All the statistical analysis was performed by using Statistical package for social sciences (SPSS) 20.0 software.

Results: Both amitriptyline and pregabalin have increased HRV and reduced neuropathic pain intensity after 2- and 4-weeks treatment. The correlation between HRV and neuropathic pain was not observed.

Conclusions: To conclude both the drugs have significantly increased HRV and reduced the pain intensity; but no correlation was observed between increased HRV and reduced pain intensity.


Keywords


Heart rate variability, Amitriptyline, Pregabalin, Neuropathic pain

Full Text:

PDF

References


Garland EL. Pain Processing in the Human Nervous System. A Selective Review of Nociceptive and Biobehavioral Pathways. Primary Care - Clinics in Office Practice. 2012;39(3):561-71.

Bennett MI. Chapter1, Theories, history and current taxonomy. In: Neuropathic pain. 2010. Ch-1;1.

Karri J, Zhang L, Li S, Chen Y-T, Stampas A, Li S. Heart Rate Variability: A Novel Modality for Diagnosing Neuropathic Pain after Spinal Cord Injury. Front Physiol. 2017;8:495.

Van Ravenswaaij-Arts C, Kollée L, Hopman J, Stoelinga G, Van Geijn H. Heart rate variability. Ann Intern Med. 1993;118(6):436-47.

Rechlin T. The Effect of Amitriptyline, Doxepin, Fluvoxamine, and Paroxetine Treatment on Heart Rate Variability. J Clin Psychopharmacol. 1994;14(6):392-5.

Vinik A, Maser R, Mitchell B, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26(5):1553-79.

Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: Current evidence and future directions. Current Opinion in Anaesthesiology. 2007; 20(5):456-72.

Ermis N, Gullu H, Caliskan M, Unsal A, Kulaksizoglu M, Muderrisoglu H. Gabapentin therapy improves heart rate variability in diabetic patients with peripheral neuropathy. J Diabetes Complications. 2010;24(4):229-33.

Jiang W, Ladd S, Martsberger C, Feinglos M, Spratt SE, Kuchibhatla M, et al. Effects of pregabalin on heart rate variability in patients with painful diabetic neuropathy. J Clin Psychopharmacol. 2011;31(2):207-13.

Chakrabarty S, Das A, Ganguly A. A prospective, randomised, comparative study of efficacy and safety of pregabalin, duloxetine and amitriptyline in patients of painful diabetic neuropathy in a tertiary care teaching hospital in rural Bengal. J Evolution Med Dent Sci. 2016;5(35):2025-29.

Kaur H, Hota D, Bhansali A, Dutta P, Bansal D, Chakrabarti A. A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: A randomized, double-blind, cross-over clinical trial. Diabetes Care. 2011;34(4):818-22.

Baidya DK, Agarwal A, Khanna P, Arora MK. Pregabalin in acute and chronic pain. J Anaesthesiol Clin Pharmacol. 2011;27:307-14.

Fink K, Meder W, Dooley DJ, Göthert M. Inhibition of neuronal Ca2+ influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol. 2000;130(4):900-6.

Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain. 2003;105(2):131-41.

Sills GJ. The mechanisms of action of gabapentin and pregabalin. Current Opinion in Pharmacology. 2006;(1):108-13.

Kweon TD, Kim JY, Kwon IW, Choi JB, Lee YW. Participation of K(ATP) Channels in the Antinociceptive Effect of Pregabalin in Rat Formalin Test. Korean J. Pain. 2011;24:131-6.

Devi P, Madhu K, Ganapathy B, Sarma G, John L, Kulkarni C. Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy. Indian J Pharmacol. 2012;44:51-6.

Chang, Ma, Tsay, Jong. Relationships between pain intensity and heart rate variability in patients after abdominal surgery: a Pilot Study. Chin J Pharmcol. 2012;125(11):1964-9.